Literature DB >> 33598778

Clinical and radiographic evaluation of 0.8% hyaluronic acid as an adjunct to open flap debridement in the treatment of periodontal intrabony defects: randomized controlled clinical trial.

Alefiya S Mamajiwala1, Kunal S Sethi1, Chetan P Raut2, Prerna A Karde1, Batul S Mamajiwala3.   

Abstract

OBJECTIVES: Present study aimed to evaluate and compare the clinical and radiographic efficacy of 0.8% hyaluronic acid (HA) gel as an adjunct to open flap debridement (OFD) versus open flap debridement (OFD) alone in the treatment of periodontal intrabony defects.
MATERIALS AND METHODS: This randomized, controlled, split-mouth, clinical trial included 20 chronic periodontitis (stage II or III (grades A to B)) patients, having at least two contralateral intrabony defects. Forty bilateral intrabony defects (20 in each group) were randomly divided into test (0.8% HA gel + OFD) and control (OFD + placebo) groups. Clinical parameters evaluated at baseline, 6-months, and 12-months were plaque index (PI), gingival index (GI), probing depth (PD), clinical attachment level (CAL), and gingival recession (GR). Using cone beam computed tomography (CBCT), radiographic parameters were evaluated at baseline and 12 months. This included bone defect fill (DF), alveolar crest changes (ACC), and defect resolution (DR). CAL served as the primary outcome variable.
RESULTS: After 12 months, the test group showed significantly greater CAL gain (5.1 ± 1.2 versus 4.05 ± 1.19 mm) and bone defect fill (DF) (5.67 ± 2.01 versus 4.49 ± 1.78 mm) compared to the control group. Mean PD reduction in the test group (5.3 ± 1.2 versus 4.35 ± 0.81 mm) was statistically significant compared to the control group at 12-month period. The control group showed statistically significant increase in GR (1.2 ± 0.76 versus 0.7 ± 0.73 mm) compared to the test group after 12 months.
CONCLUSION: Application of hyaluronic acid gel in conjunction with open flap debridement resulted in enhanced clinical and radiographic outcomes compared to open flap debridement alone. CLINICAL RELEVANCE: Adjunctive application of HA gel in open flap debridement may improve clinical and radiographic outcomes. CLINICAL TRIAL REGISTERED NUMBER: CTRI/2018/03/012334.

Entities:  

Keywords:  Chronic periodontitis; Hyaluronic acid; Periodontal bone loss; Periodontal debridement; Periodontal regeneration; Randomized controlled trial

Year:  2021        PMID: 33598778     DOI: 10.1007/s00784-021-03834-7

Source DB:  PubMed          Journal:  Clin Oral Investig        ISSN: 1432-6981            Impact factor:   3.573


  41 in total

Review 1.  Diagnosis and epidemiology of periodontal osseous lesions.

Authors:  P N Papapanou; M S Tonetti
Journal:  Periodontol 2000       Date:  2000-02       Impact factor: 7.589

2.  Enamel matrix proteins in the regenerative therapy of deep intrabony defects.

Authors:  Maurizio S Tonetti; Niklaus P Lang; Pierpaolo Cortellini; Jean E Suvan; Patrick Adriaens; Dominik Dubravec; Alberto Fonzar; Ioannis Fourmousis; Lisa Mayfield; Roberto Rossi; Maurizio Silvestri; Christine Tiedemann; Heinz Topoll; Tine Vangsted; Beat Wallkamm
Journal:  J Clin Periodontol       Date:  2002-04       Impact factor: 8.728

3.  Enamel matrix derivative, alone or associated with a synthetic bone substitute, in the treatment of 1- to 2-wall periodontal defects.

Authors:  Dario De Leonardis; Michele Paolantonio
Journal:  J Periodontol       Date:  2012-05-21       Impact factor: 6.993

4.  Multi-centre, randomized clinical trial on the efficacy and safety of recombinant human platelet-derived growth factor with β-tricalcium phosphate in human intra-osseous periodontal defects.

Authors:  Avula Jayakumar; Palaparthi Rajababu; Surabhi Rohini; Kalakonda Butchibabu; Anumala Naveen; Pathakota Krishnajaneya Reddy; Sisinty Vidyasagar; Durvasula Satyanarayana; Sayini Pavan Kumar
Journal:  J Clin Periodontol       Date:  2010-12-06       Impact factor: 8.728

5.  Clinical outcomes after treatment of non-contained intrabony defects with enamel matrix derivative or guided tissue regeneration: a 12-month randomized controlled clinical trial.

Authors:  Vincenzo Iorio Siciliano; Gianmaria Andreuccetti; Alessandro Iorio Siciliano; Andrea Blasi; Anton Sculean; Giovanni E Salvi
Journal:  J Periodontol       Date:  2010-09-01       Impact factor: 6.993

Review 6.  The efficacy of bone replacement grafts in the treatment of periodontal osseous defects. A systematic review.

Authors:  Mark A Reynolds; Mary Elizabeth Aichelmann-Reidy; Grishondra L Branch-Mays; John C Gunsolley
Journal:  Ann Periodontol       Date:  2003-12

Review 7.  Guided tissue regeneration for the treatment of periodontal intrabony and furcation defects. A systematic review.

Authors:  Kevin G Murphy; John C Gunsolley
Journal:  Ann Periodontol       Date:  2003-12

Review 8.  Periodontal regeneration - intrabony defects: a systematic review from the AAP Regeneration Workshop.

Authors:  Richard T Kao; Salvador Nares; Mark A Reynolds
Journal:  J Periodontol       Date:  2014-09-12       Impact factor: 6.993

Review 9.  Hyaluronic acid: Perspectives in dentistry. A systematic review.

Authors:  Manuele Casale; Antonio Moffa; Paola Vella; Lorenzo Sabatino; Francesco Capuano; Beatrice Salvinelli; Michele Antonio Lopez; Francesco Carinci; Fabrizio Salvinelli
Journal:  Int J Immunopathol Pharmacol       Date:  2016-06-08       Impact factor: 3.219

10.  Hyaluronic Acid: a boon in periodontal therapy.

Authors:  Parveen Dahiya; Reet Kamal
Journal:  N Am J Med Sci       Date:  2013-05
View more
  3 in total

Review 1.  Efficiency of Hyaluronic Acid in Infrabony Defects: A Systematic Review of Human Clinical Trials.

Authors:  Florin Onisor; Simion Bran; Alexandru Mester; Andrada Voina-Tonea
Journal:  Medicina (Kaunas)       Date:  2022-04-23       Impact factor: 2.948

2.  Evaluation of Therapeutic Benefits of a Novel Herbal Ingredient-Based Hyaluronic Acid Gel as Monotherapy for Inflammatory Enlargement of a Patient with Diabetes Mellitus.

Authors:  Jaahnavi Lanka; Santhosh Kumar
Journal:  Case Rep Dent       Date:  2022-02-04

3.  High Molecular Weight Hyaluronic Acid Reduces the Expression of Virulence Genes fimA, mfa1, hagA, rgpA, and kgp in the Oral Pathogen Porphyromonas gingivalis.

Authors:  Meshal S Alharbi; Fahad A Alshehri
Journal:  Pharmaceutics       Date:  2022-08-04       Impact factor: 6.525

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.